The immunohistochemical analysis and TUNEL apoptosis assays and LYVE-1 staining were performed to directly evaluate whether YL529 could inhibit the tumor lymphangiogenesis and induce tumor cell apoptosis in vivo. The gene discussed is LYVE1; the disease is neoplasm.